{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:36:16Z","timestamp":1773149776769,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,9]]},"DOI":"10.7759\/cureus.104937","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:07:30Z","timestamp":1773094050000},"source":"Crossref","is-referenced-by-count":0,"title":["Steroid-Refractory Warm Autoimmune Haemolytic Anaemia Complicating Ulcerative Colitis in Pregnancy: A Case Report and Management Considerations"],"prefix":"10.7759","author":[{"given":"Jimmy","family":"William","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Lahiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Couto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00946","article-title":"The changing landscape of autoimmune hemolytic anemia","volume":"11","author":"Barcellini W","year":"2020","unstructured":"Barcellini W, Fattizzo B. The changing landscape of autoimmune hemolytic anemia. Front Immunol. 2020, 11:946. 10.3389\/fimmu.2020.00946","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V41.2.293.293","article-title":"Autoimmune hemolytic anemia during pregnancy with hemolytic disease in the newborn","volume":"41","author":"Baumann R","year":"1973","unstructured":"Baumann R, Rubin H. Autoimmune hemolytic anemia during pregnancy with hemolytic disease in the newborn. Blood. 1973, 41:293-7. 10.1182\/blood.V41.2.293.293","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.022","article-title":"Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group","volume":"156","author":"Mahadevan U","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N, et al.. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the American Gastroenterological Association IBD Parenthood Project Working Group. Gastroenterology. 2019, 156:1508-24. 10.1053\/j.gastro.2018.12.022","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1558131","article-title":"Pregnancy induced autoimmune warm antibodies hemolytic anemia: a case report","volume":"75","author":"Lau\u017eikien\u0117 D","year":"2015","unstructured":"Lau\u017eikien\u0117 D, Rama\u0161auskait\u0117 D, L\u016b\u017ea T, Lenkutien\u0117 R. Pregnancy induced autoimmune warm antibodies hemolytic anemia: a case report. Geburtshilfe Frauenheilkd. 2015, 75:1167-71. 10.1055\/s-0035-1558131","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000287292.74846.f2","article-title":"Pregnancy-induced hemolytic anemia with a possible immune-related mechanism","volume":"111","author":"Katsuragi S","year":"2008","unstructured":"Katsuragi S, Sameshima H, Omine M, Ikenoue T. Pregnancy-induced hemolytic anemia with a possible immune-related mechanism. Obstet Gynecol. 2008, 111:528-9. 10.1097\/01.AOG.0000287292.74846.f2","journal-title":"Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(90)90099-m","article-title":"Autoimmune haemolytic anaemia in pregnancy: a case report","volume":"37","author":"Ng SC","year":"1990","unstructured":"Ng SC, Wong KK, Raman S, Bosco J. Autoimmune haemolytic anaemia in pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol. 1990, 37:83-5. 10.1016\/0028-2243(90)90099-m","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018890","article-title":"Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience","volume":"141","author":"Fattizzo B","year":"2023","unstructured":"Fattizzo B, Bortolotti M, Fantini NN, et al.. Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience. Blood. 2023, 141:2016-21. 10.1182\/blood.2022018890","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-156656","article-title":"Autoimmune haemolytic anemia during pregnancy and post-partum: an international multi-center experience","volume":"140","author":"Bortolotti M","year":"2022","unstructured":"Bortolotti M, Fantini N, Glenth\u00f8j A, et al.. Autoimmune haemolytic anemia during pregnancy and post-partum: an international multi-center experience. Blood. 2022, 140:2440-2. 10.1182\/blood-2022-156656","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14654","article-title":"Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia","volume":"177","author":"Hill QA","year":"2017","unstructured":"Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017, 177:208-20. 10.1111\/bjh.14654","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2024-260586","article-title":"Case of autoimmune haemolytic anaemia, possibly secondary to vedolizumab in ulcerative colitis, successfully treated with rituximab","volume":"17","author":"Temido MJ","year":"2024","unstructured":"Temido MJ, Lopes S, Figueiredo P, Portela F. Case of autoimmune haemolytic anaemia, possibly secondary to vedolizumab in ulcerative colitis, successfully treated with rituximab. BMJ Case Rep. 2024, 17:e260586. 10.1136\/bcr-2024-260586","journal-title":"BMJ Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2022.2089115","article-title":"Autoimmune hemolytic anemia: causes and consequences","volume":"18","author":"Fattizzo B","year":"2022","unstructured":"Fattizzo B, Barcellini W. Autoimmune hemolytic anemia: causes and consequences. Expert Rev Clin Immunol. 2022, 18:731-45. 10.1080\/1744666X.2022.2089115","journal-title":"Expert Rev Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1548321","article-title":"Case report: hemolytic anemia secondary to infliximab treatment in a patient with ulcerative colitis","volume":"12","author":"Bevivino G","year":"2025","unstructured":"Bevivino G, Scarozza P, Di Fonzo M, Zerboni G, Iacopini F. Case report: hemolytic anemia secondary to infliximab treatment in a patient with ulcerative colitis. Front Med (Lausanne). 2025, 12:1548321. 10.3389\/fmed.2025.1548321","journal-title":"Front Med (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23248","article-title":"Corticosteroid use and risk of orofacial clefts","volume":"100","author":"Skuladottir H","year":"2014","unstructured":"Skuladottir H, Wilcox AJ, Ma C, et al.. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014, 100:499-506. 10.1002\/bdra.23248","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325317","article-title":"Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry","volume":"71","author":"Odufalu FD","year":"2022","unstructured":"Odufalu FD, Long M, Lin K, Mahadevan U. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry. Gut. 2022, 71:1766-72. 10.1136\/gutjnl-2021-325317","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.11.038","article-title":"Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease","volume":"160","author":"Mahadevan U","year":"2021","unstructured":"Mahadevan U, Long MD, Kane SV, et al.. Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease. Gastroenterology. 2021, 160:1131-9. 10.1053\/j.gastro.2020.11.038","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15539","article-title":"Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study","volume":"51","author":"Moens A","year":"2020","unstructured":"Moens A, van der Woude CJ, Julsgaard M, et al.. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Aliment Pharmacol Ther. 2020, 51:129-38. 10.1111\/apt.15539","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty EF","year":"2011","unstructured":"Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011, 117:1499-506. 10.1182\/blood-2010-07-295444","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev405","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part II: analgesics and other drugs used in rheumatology practice","volume":"55","author":"Flint J","year":"2016","unstructured":"Flint J, Panchal S, Hurrell A, et al.. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part II: analgesics and other drugs used in rheumatology practice. Rheumatology (Oxford). 2016, 55:1698-702. 10.1093\/rheumatology\/kev405","journal-title":"Rheumatology (Oxford)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000453","article-title":"Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD","volume":"5","author":"Das G","year":"2018","unstructured":"Das G, Damotte V, Gelfand JM, et al.. Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm. 2018, 5:e453. 10.1212\/NXI.0000000000000453","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011798","article-title":"Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis","volume":"8","author":"Fattizzo B","year":"2024","unstructured":"Fattizzo B, Pedone GL, Brambilla C, Pettine L, Zaninoni A, Passamonti F, Barcellini W. Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis. Blood Adv. 2024, 8:1322-7. 10.1182\/bloodadvances.2023011798","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/469747-steroid-refractory-warm-autoimmune-haemolytic-anaemia-complicating-ulcerative-colitis-in-pregnancy-a-case-report-and-management-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:07:32Z","timestamp":1773094052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/469747-steroid-refractory-warm-autoimmune-haemolytic-anaemia-complicating-ulcerative-colitis-in-pregnancy-a-case-report-and-management-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.104937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}